Developer docs
API playgroundTry for free, no card

Search company profiles

VinBrain

Full company profile

uuid0007gyl

Namestring
VinBrain
Legal namestring
VinBrain
Websiteurl
vinbrain.net
Company typeenum
Private
Founded yearint
2019
Descriptiontext

VinBrain is a Vietnam-headquartered artificial intelligence company founded in 2019 that builds AI-powered diagnostic systems and computer-aided detection software for medical imaging. The company operates in the healthcare vertical, serving providers and imaging facilities that require early disease detection capabilities. Its core technology stack centers on proprietary AI models applied to radiological and medical imaging workflows, positioning it as a verticalized AI application layer rather than a general-purpose model provider.

The company's go-to-market was oriented toward healthcare institutions in Vietnam and, by implication, the broader Southeast Asian market. Revenue mechanics are not publicly disclosed — no pricing model, contract structure, or per-seat or per-imaging economics appear in available sources — and no named customer logos are documented. Headcount of 51-100 employees is consistent with an early-stage commercial-stage AI application company.

In 2025, Nvidia acquired VinBrain as part of Vietnam's mega M&A transactions, integrating the company into its Healthcare and Life Sciences platform. The acquisition coincides with Nvidia's broader partnership with Vietnam on a national AI R&D Center and $200 million AI factory, giving the combined entity access to hyperscaler-scale compute infrastructure and government-backed ecosystem positioning. Pre-acquisition, VinBrain had been recognized by MedTech Innovator in mid-2024 as a notable medical technology innovator.

Short descriptiontext

VinBrain, founded in 2019 in Hanoi, Vietnam, builds AI-powered diagnostic and computer-aided detection systems for medical imaging, serving healthcare providers. Acquired by Nvidia in 2025, it now operates within Nvidia's global Healthcare and Life Sciences platform.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHanoi, Vietnam
HQ citystring
Hanoi
HQ countrystring
Vietnam
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
medical imaging AI, diagnostic software, computer-aided detection, healthcare AI solutions, medical image analysis
Industry3 codes
1Radiology AI, CAD & Advanced Visualization Software
CodeHLAHABAJPrimaryYes
2Medical Imaging AI
CodeHDAAAEAHPrimaryNo
3SaMD – Imaging & Signal Analysis (AI/ML)
CodeHLACANAGPrimaryNo
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Software Publishers5132
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Healthcare AI Medical Imaging
Social media profiles3 records
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

VinBrain develops and provides AI-powered diagnostic software for medical imaging, including computer-aided detection systems that assist healthcare providers in early disease diagnosis. The company's offerings are aimed at hospitals, clinics, and medical imaging facilities seeking AI-augmented interpretation of diagnostic images.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1AI-Powered Medical Imaging Diagnostic System
CategoryHealthcare AI / Medical Imaging
Description

AI-powered diagnostic software designed to assist healthcare providers and medical imaging facilities with computer-aided detection and early disease diagnosis through deep learning-based image interpretation.

2Computer-Aided Detection Platform
CategoryHealthcare AI / Medical Imaging
Description

Software platform providing computer-aided detection capabilities for medical imaging, helping clinicians identify abnormalities and disease markers in diagnostic images.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Nvidia partnered with Vietnam on an AI R&D center and $200 million AI factory, positioning Vietnam as an emerging AI power alongside the UAE and Saudi Arabia. VinBrain, as a Vietnamese AI healthcare company, benefits from this national AI infrastructure development.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based AI platform for medical imaging, particularly stroke and cardiovascular triage. Comparable as a specialist AI imaging company focused on time-sensitive diagnostic workflows in hospital settings.

TypeDirect peer
Description

South Korean medical AI company providing AI-powered image analysis for cancer detection and chest X-ray triage. Comparable as an Asia-based radiology AI company with global ambitions.

TypeDirect peer
Description

US-based cloud-native medical imaging AI platform with FDA-cleared products for cardiac and oncology imaging. Comparable as an AI-only imaging analytics vendor operating in hospital radiology workflows.

TypeDirect peer
Description

Israeli medical imaging AI company offering AI-powered triage and detection across CT, MRI, and X-ray. Directly comparable as a dedicated radiology AI vendor serving hospitals with similar clinical workflows.

TypeDirect peer
Description

Imaging AI subsidiary of Nanox offering AI algorithms for medical imaging analysis. Comparable as a radiology AI specialist focused on disease detection from standard imaging modalities.

TypeDirect peer
Description

Australia-based medical imaging AI company offering comprehensive X-ray and CT detection. Comparable in clinical scope, AI-only focus, and emerging-market origins similar to VinBrain.

TypeDirect peer
Description

India-based AI company focused on medical imaging interpretation, particularly for chest X-ray, head CT, and tuberculosis screening. Comparable as an emerging-market radiology AI specialist with similar clinical focus areas.

TypeBroad incumbent
Description

Major medical imaging OEM offering AI-Rad Companion for AI-augmented radiology reporting. Comparable as a large incumbent bundling AI capabilities with installed imaging equipment base.

TypeDirect peer
Description

AI-powered radiology subsidiary of RadNet offering breast, lung, and prostate cancer detection. Comparable as a vertically integrated imaging AI company with similar diagnostic focus areas.

TypeBroad incumbent
Description

Global medical imaging OEM with embedded AI capabilities across its PACS and modality portfolio. Comparable as a broader healthcare imaging player whose AI offerings compete with specialty vendors like VinBrain.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VinBrain

Healthcare AI Medical Imagingvinbrain.net

VinBrain, founded in 2019 in Hanoi, Vietnam, builds AI-powered diagnostic and computer-aided detection systems for medical imaging, serving healthcare providers. Acquired by Nvidia in 2025, it now operates within Nvidia's global Healthcare and Life Sciences platform.

What VinBrain does

VinBrain is a Vietnam-headquartered artificial intelligence company founded in 2019 that builds AI-powered diagnostic systems and computer-aided detection software for medical imaging. The company operates in the healthcare vertical, serving providers and imaging facilities that require early disease detection capabilities. Its core technology stack centers on proprietary AI models applied to radiological and medical imaging workflows, positioning it as a verticalized AI application layer rather than a general-purpose model provider.

The company's go-to-market was oriented toward healthcare institutions in Vietnam and, by implication, the broader Southeast Asian market. Revenue mechanics are not publicly disclosed — no pricing model, contract structure, or per-seat or per-imaging economics appear in available sources — and no named customer logos are documented. Headcount of 51-100 employees is consistent with an early-stage commercial-stage AI application company.

In 2025, Nvidia acquired VinBrain as part of Vietnam's mega M&A transactions, integrating the company into its Healthcare and Life Sciences platform. The acquisition coincides with Nvidia's broader partnership with Vietnam on a national AI R&D Center and $200 million AI factory, giving the combined entity access to hyperscaler-scale compute infrastructure and government-backed ecosystem positioning. Pre-acquisition, VinBrain had been recognized by MedTech Innovator in mid-2024 as a notable medical technology innovator.

VinBrain firmographics

Firmographics
Name
VinBrain
Legal name
VinBrain
Website
https://vinbrain.net
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
51–100 employees
Short description
VinBrain, founded in 2019 in Hanoi, Vietnam, builds AI-powered diagnostic and computer-aided detection systems for medical imaging, serving healthcare providers. Acquired by Nvidia in 2025, it now operates within Nvidia's global Healthcare and Life Sciences platform.
Ownership category
akta.pro rank

VinBrain industry classification

Industry
Product category
Healthcare AI Medical Imaging
NAICS
Medical Equipment and Supplies Manufacturing (3391), Software Publishers (5132)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
akta.pro secondary industries
Medical Imaging AI (HDAAAEAH), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

Keywords

  • Medical imaging AI
  • Diagnostic software
  • Computer-aided detection
  • Healthcare AI solutions
  • Medical image analysis

Where VinBrain is headquartered

Location

Headquarters

HQ city
Hanoi
HQ country
Vietnam
HQ region
Asia

Markets served

VinBrain business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure

VinBrain product offering

Product offering

Core offering

VinBrain develops and provides AI-powered diagnostic software for medical imaging, including computer-aided detection systems that assist healthcare providers in early disease diagnosis. The company's offerings are aimed at hospitals, clinics, and medical imaging facilities seeking AI-augmented interpretation of diagnostic images.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI-Powered Medical Imaging Diagnostic System AI-powered diagnostic software designed to assist healthcare providers and medical imaging facilities with computer-aided detection and early disease diagnosis through deep learning-based image interpretation.
  • Computer-Aided Detection Platform Software platform providing computer-aided detection capabilities for medical imaging, helping clinicians identify abnormalities and disease markers in diagnostic images.

Companies that use VinBrain

Customer profile

Segments1 record

Ideal customer profiles1 record

VinBrain technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

VinBrain partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Nvidia (Vietnam AI R&D Center Partnership)flagshipStrategic or Co-development PartnerNvidia partnered with Vietnam on an AI R&D center and $200 million AI factory, positioning Vietnam as an emerging AI power alongside the UAE and Saudi Arabia. VinBrain, as a Vietnamese AI healthcare company, benefits from this national AI infrastructure development.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

VinBrain competitors and assessment

Company assessment

Direct peers

  • Viz.ai: US-based AI platform for medical imaging, particularly stroke and cardiovascular triage. Comparable as a specialist AI imaging company focused on time-sensitive diagnostic workflows in hospital settings.
  • Lunit: South Korean medical AI company providing AI-powered image analysis for cancer detection and chest X-ray triage. Comparable as an Asia-based radiology AI company with global ambitions.
  • Arterys: US-based cloud-native medical imaging AI platform with FDA-cleared products for cardiac and oncology imaging. Comparable as an AI-only imaging analytics vendor operating in hospital radiology workflows.
  • Aidoc: Israeli medical imaging AI company offering AI-powered triage and detection across CT, MRI, and X-ray. Directly comparable as a dedicated radiology AI vendor serving hospitals with similar clinical workflows.
  • Nanox (Zebra Medical Vision): Imaging AI subsidiary of Nanox offering AI algorithms for medical imaging analysis. Comparable as a radiology AI specialist focused on disease detection from standard imaging modalities.
  • Annalise.ai: Australia-based medical imaging AI company offering comprehensive X-ray and CT detection. Comparable in clinical scope, AI-only focus, and emerging-market origins similar to VinBrain.
  • Qure.ai: India-based AI company focused on medical imaging interpretation, particularly for chest X-ray, head CT, and tuberculosis screening. Comparable as an emerging-market radiology AI specialist with similar clinical focus areas.
  • DeepHealth (RadNet): AI-powered radiology subsidiary of RadNet offering breast, lung, and prostate cancer detection. Comparable as a vertically integrated imaging AI company with similar diagnostic focus areas.

Broad incumbents

  • Siemens Healthineers (AI-Rad Companion): Major medical imaging OEM offering AI-Rad Companion for AI-augmented radiology reporting. Comparable as a large incumbent bundling AI capabilities with installed imaging equipment base.
  • Philips (IntelliSpace AI): Global medical imaging OEM with embedded AI capabilities across its PACS and modality portfolio. Comparable as a broader healthcare imaging player whose AI offerings compete with specialty vendors like VinBrain.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

VinBrain social profiles

Digital presence

VinBrain financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VinBrain leadership team

Management profile

Number of profiles

VinBrain funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VinBrain M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VinBrain

What does VinBrain do?

VinBrain develops and provides AI-powered diagnostic software for medical imaging, including computer-aided detection systems that assist healthcare providers in early disease diagnosis. The company's offerings are aimed at hospitals, clinics, and medical imaging facilities seeking AI-augmented interpretation of diagnostic images.

Is VinBrain a public or private company?

VinBrain is a private company. It is classified as corporate owned and is currently acquired.

When was VinBrain founded?

VinBrain was founded in 2019. It employs 51 to 100 people.

Where is VinBrain based?

VinBrain is headquartered in Hanoi, Vietnam, in the Asia region.

Who are VinBrain's main competitors?

Direct peers on record are Viz.ai, Lunit, Arterys, Aidoc, Nanox (Zebra Medical Vision), Annalise.ai, Qure.ai and DeepHealth (RadNet). Broad incumbents are Siemens Healthineers (AI-Rad Companion) and Philips (IntelliSpace AI).

Does VinBrain have an API?

No public API is recorded for VinBrain.

What industry is VinBrain in?

VinBrain's product category is Healthcare AI Medical Imaging. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Signify ResearchAI in Medical Imaging News Round-up – December 2024Several companies in the AI in Medical Imaging industry announced acquisitions, product launches, funding rounds, partnerships, and regulatory updates in December 2024. Notable developments include NVIDIA's acquisition of VinBrain, Cleerly raising $106 million, and collaborations involving Blackford, Bayer, Viz.ai, and others to expand AI-driven medical imaging solutions.Hitnews'Early diagnosis of dementia' ViewBrain Healthcare secures 3 billion pre-Series A investmentViewBrain Healthcare has secured a 3 billion pre-Series A investment to support its operations and expansion plans. The company intends to begin the FDA approval process next year for its brain MRI imaging analysis solution, which utilizes a dementia database larger than ADNI.PR NewswireVinBrain wins ACM SIGAI Industry Award 2021 for Excellence in Artificial IntelligenceVinBrain, a subsidiary of Vingroup based in Vietnam, won the 2021 ACM SIGAI Industry Award for Excellence in Artificial Intelligence for its DrAidTM AI-powered radiology assistant product. The award, previously granted to Microsoft in 2019 and one of the world's top AI recognitions, was presented at IJCAI 2021 in Canada, highlighting the product's advanced capabilities including detection of over 21 abnormalities with 89% accuracy and COVID-19 screening from chest X-rays. DrAidTM is currently deployed in 84 hospitals and medical facilities across Vietnam.PR NewswireVinBrain and FIT Jointly Release a White Paper on Utilizing Artificial Intelligence in Tuberculosis ScreeningOn June 10, 2021, VinBrain (Vingroup) and FIT, a German NGO focused on tuberculosis prevention, jointly released a white paper on using artificial intelligence for TB diagnosis and screening in Vietnam. The AI model developed by VinBrain achieved 86% sensitivity and 96.1% specificity in TB detection, using over 185,000 filtered chest X-ray images collected from Vietnam, India, and China. The model has been integrated into VinBrain's DrAid product, an AI-powered medical assistant deployed across 84 hospitals and medical facilities in Vietnam.NVIDIA BlogVinBrain improves quality of healthcare with AI-infused solutionsVinBrain, a Vietnamese AI healthcare firm, developed DrAid, an AI-based chest X-ray diagnosis tool, using NVIDIA DGX A100 supercomputers. The tool is deployed in 63 health facilities in Vietnam and will expand to 150 more in Vietnam and 7 in Myanmar this year. The company plans to use the system for upcoming conversational AI and prognosis recommendation projects.